Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schraml

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Nucleic Acids Research|December 20, 2019
Spatially multiplexed RNA in situ hybridization to reveal tumor heterogeneityLena Voith von Voithenberg, Anna Fomitcheva Khartchenko, Deborah Huber, et al.
Nature Biomedical Engineering|April 10, 2019
Quantitative microimmunohistochemistry for the grading of immunostains on tumour tissuesAditya Kashyap, Anna Fomitcheva Khartchenko, Pushpak Pati, et al.
Cancer Research|July 1, 2011
VHL gene mutations and their effects on hypoxia inducible factor HIFα: identification of potential driver and passenger mutationsMarkus P Rechsteiner, Adriana von Teichman, Anna Nowicka, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2011
Characterization of periostin isoform pattern in non-small cell lung cancerLaura Morra, Markus Rechsteiner, Silvia Casagrande, et al.
Frontiers in Cell and Developmental Biology|November 8, 2019
Cancer Sample Biobanking at the Next Level: Combining Tissue With Living Cell Repositories to Promote Precision MedicineHella A Bolck, Chantal Pauli, Elisabeth Göbel, et al.
The Journal of Pathology. Clinical Research|March 31, 2023
Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinomaPeter Schraml, Fabio Aimi, Martin Zoche, et al.
Anticancer Research|March 16, 2004
Molecular and clinicopathological analysis of ovarian carcinomas with and without microsatellite instabilityAthanassios Dellas, Alex Puhl, Peter Schraml, et al.
European Urology|May 19, 2009
Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept studyFrantisek Zát'ura, Jaroslav Vsetica, Montserrat Abadías, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2023
Analysis of the PARP1, ADP-Ribosylation, and TRIP12 Triad With Markers of Patient Outcome in Human Breast CancerAswini Krishnan, Vincent Spegg, Susanne Dettwiler, et al.
Cancers|February 22, 2020
Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma PatientsRiuko Ohashi, Silvia Angori, Aashil A Batavia, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Nucleic Acids Research|December 20, 2019
Spatially multiplexed RNA in situ hybridization to reveal tumor heterogeneityLena Voith von Voithenberg, Anna Fomitcheva Khartchenko, Deborah Huber, et al.
Nature Biomedical Engineering|April 10, 2019
Quantitative microimmunohistochemistry for the grading of immunostains on tumour tissuesAditya Kashyap, Anna Fomitcheva Khartchenko, Pushpak Pati, et al.
Cancer Research|July 1, 2011
VHL gene mutations and their effects on hypoxia inducible factor HIFα: identification of potential driver and passenger mutationsMarkus P Rechsteiner, Adriana von Teichman, Anna Nowicka, et al.
Lung Cancer (Amsterdam, Netherlands)|November 15, 2011
Characterization of periostin isoform pattern in non-small cell lung cancerLaura Morra, Markus Rechsteiner, Silvia Casagrande, et al.
Frontiers in Cell and Developmental Biology|November 8, 2019
Cancer Sample Biobanking at the Next Level: Combining Tissue With Living Cell Repositories to Promote Precision MedicineHella A Bolck, Chantal Pauli, Elisabeth Göbel, et al.
The Journal of Pathology. Clinical Research|March 31, 2023
Altered cytoplasmic and nuclear ADP-ribosylation levels analyzed with an improved ADP-ribose binder are a prognostic factor in renal cell carcinomaPeter Schraml, Fabio Aimi, Martin Zoche, et al.
Anticancer Research|March 16, 2004
Molecular and clinicopathological analysis of ovarian carcinomas with and without microsatellite instabilityAthanassios Dellas, Alex Puhl, Peter Schraml, et al.
European Urology|May 19, 2009
Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept studyFrantisek Zát'ura, Jaroslav Vsetica, Montserrat Abadías, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 29, 2023
Analysis of the PARP1, ADP-Ribosylation, and TRIP12 Triad With Markers of Patient Outcome in Human Breast CancerAswini Krishnan, Vincent Spegg, Susanne Dettwiler, et al.
Cancers|February 22, 2020
Loss of CDKN1A mRNA and Protein Expression Are Independent Predictors of Poor Outcome in Chromophobe Renal Cell Carcinoma PatientsRiuko Ohashi, Silvia Angori, Aashil A Batavia, et al.
Pageof 12